{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:12:14Z","timestamp":1784041934961,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000805","name":"European Centre for Disease Prevention and Control","doi-asserted-by":"crossref","award":["ECDC\/2021\/017"],"award-info":[{"award-number":["ECDC\/2021\/017"]}],"id":[{"id":"10.13039\/501100000805","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000805","name":"European Centre for Disease Prevention and Control","doi-asserted-by":"crossref","award":["ECDC\/2021\/017"],"award-info":[{"award-number":["ECDC\/2021\/017"]}],"id":[{"id":"10.13039\/501100000805","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000805","name":"European Centre for Disease Prevention and Control","doi-asserted-by":"crossref","award":["ECDC\/2021\/017"],"award-info":[{"award-number":["ECDC\/2021\/017"]}],"id":[{"id":"10.13039\/501100000805","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Healthcare workers (HCWs) are essential frontline responders to public health emergencies and are one of the risk groups targeted by annual vaccination campaigns. Serological studies are valuable for high-risk groups such as HCWs, as they contribute to assess vulnerability, monitor infection control measures, and guide vaccination strategies in high-risk settings. This study aimed to assess humoral response at baseline, 3 and 6 months after the 2023\u20132024 COVID-19 vaccination campaign in HCWs, and to identify demographic and clinical factors associated with variations in antibody levels over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prospective cohort study of vaccinated HCWs at a central hospital in Portugal (September 2023\u2013May 2024). Serial serological tests to assess anti-spike receptor-binding domain (anti-RBD\/S) and anti-nucleocapsid protein (anti-N) IgG antibodies were used to monitor the immune response and SARS-CoV-2 infection history, respectively. Wilcoxon signed-rank tests were used to assess changes in antibody levels over time, and linear regression models were used to identify factors associated with variations in SARS-CoV-2 anti-RBD\/S IgG concentrations, on the basis of available demographic and clinical data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In a cohort of 166 HCWs who received the 2023\u20132024 COVID-19 booster vaccine, anti-RBD\/S IgG antibody levels significantly increased at 3 months post-vaccination (16 007.4 vs. 30 572.9 AU\/mL) before declining by 6 months (18 327.3 AU\/mL), nearing baseline levels. Previous infection (\u03b2\u2009=\u20091.92, 95% CI: 1.33-2.77) and older age (\u03b2\u2009=\u20092.65, 95%CI: 1.64\u20104.29) were associated with higher antibody concentrations at baseline, whereas smoking was linked to lower antibody levels at 6 months (\u03b2\u2009=\u20090.32, 95%CI: 0.11\u20130.88). Other factors, such as sex and chronic conditions, had no consistent significant impact over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although SARS-CoV-2 anti-RBD\/S IgG antibody concentrations declined significantly six months after the 2023\u20132024 COVID-19 booster vaccination, they remained at relatively high concentrations over the follow-up period. This study provides new insight into these dynamics in a highly vaccinated and exposed HCWs cohort during a later post-pandemic phase, highlighting the influence of prior infection, age, and smoking on antibody persistence and reinforces the relevance of ongoing immune monitoring of this risk group to guide tailored control strategies. However, vaccine effectiveness studies in highly exposed and vaccinated populations, such as HCWs, are needed to better inform the role of antibody monitoring in this context, especially given the ongoing trend of annually updated vaccines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13571-5","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:56:09Z","timestamp":1779209769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["COVID-19 vaccination and antibody response in healthcare workers: a longitudinal serological study following the 2023\u20132024 COVID-19 vaccination campaign"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8564-1098","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Almeida Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palmira","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Guiomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ausenda","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e2nia","family":"Gaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"13571_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2021-052130","volume":"12","author":"M Atzl","year":"2022","unstructured":"Atzl M, Muendlein A, Winder T, Fraunberger P, Brandtner EM, Geiger K, et al. SARS-CoV-2 RBD-specific and NP-specific antibody response of healthcare workers in the westernmost Austrian state Vorarlberg: a prospective cohort study. BMJ Open. 2022;12:1\u20139.","journal-title":"BMJ Open"},{"key":"13571_CR2","doi-asserted-by":"crossref","unstructured":"Garcia-Basteiro AL, Moncunill G, Tortajada M, Vidal M, Guinovart C, Jim\u00e9nez A, et al. Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital. Nat Commun. 2020;11.","DOI":"10.1038\/s41467-020-17318-x"},{"key":"13571_CR3","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ijregi.2022.03.013","volume":"3","author":"N Caballero","year":"2022","unstructured":"Caballero N, Nieto MA, Suarez-Zamora DA, Moreno S, Remolina CI, Dur\u00e1n D, et al. Prevalence of SARS-CoV-2 infection and SARS-CoV-2-specific antibody detection among healthcare workers and hospital staff of a university hospital in Colombia. IJID Reg. 2022;3:150\u20136.","journal-title":"IJID Reg"},{"key":"13571_CR4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/ijerph19010146","volume":"19","author":"T Dzinamarira","year":"2021","unstructured":"Dzinamarira T, Murewanhema G, Mhango M, Iradukunda PG, Chitungo I, Mashora M, et al. COVID-19 Prevalence among Healthcare Workers. A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2021;19:146.","journal-title":"Int J Environ Res Public Health"},{"key":"13571_CR5","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.1038\/s41598-025-89472-5","volume":"15","author":"A Bansal","year":"2025","unstructured":"Bansal A, Trieu M-C, Eriksson EM, Zhou F, McVernon J, Brokstad KA, et al. SARS-CoV-2 infection rates and associated risk factors in healthcare workers: systematic review and meta-analysis. Sci Rep. 2025;15:4705.","journal-title":"Sci Rep"},{"key":"13571_CR6","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1056\/NEJMc2103916","volume":"384","author":"N Doria-Rose","year":"2021","unstructured":"Doria-Rose N, Suthar MS, Makowski M, O\u2019Connell S, McDermott AB, Flach B, et al. Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19. N Engl J Med. 2021;384:2259\u201361.","journal-title":"N Engl J Med"},{"key":"13571_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2147\/OAJCT.S471245","volume":"16","author":"R Girsang","year":"2024","unstructured":"Girsang R, Fadlyana E, Rusmil K, Dwi Putra M, Utami R, Putri A, et al. Long Term Follow Up of Antibody Titres Against SARS-CoV-2 6 Months After Primary Protein Subunit COVID-19 Vaccination (ZF2001) in Indonesian Adults and Older Adults. Open Access J Clin Trials. 2024;16:41\u20138.","journal-title":"Open Access J Clin Trials"},{"key":"13571_CR8","first-page":"1","volume":"14","author":"MA Haq","year":"2024","unstructured":"Haq MA, Roy AK, Ahmed R, Kuddusi RU, Sinha M, Hossain MS, et al. Antibody longevity and waning following COVID-19 vaccination in a 1-year longitudinal cohort in Bangladesh. Sci Rep. 2024;14:1\u201311.","journal-title":"Sci Rep"},{"key":"13571_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-12809-x","volume":"12","author":"G Igawa","year":"2022","unstructured":"Igawa G, Ai T, Yamamoto T, Ito K, Nojiri S, Saito K, et al. Antibody response and seroprevalence in healthcare workers after the BNT162b2 vaccination in a University Hospital at Tokyo. Sci Rep. 2022;12:1\u20139.","journal-title":"Sci Rep"},{"key":"13571_CR10","doi-asserted-by":"publisher","first-page":"e043584","DOI":"10.1136\/bmjopen-2020-043584","volume":"11","author":"JE Ebinger","year":"2021","unstructured":"Ebinger JE, Botwin GJ, Albert CM, Alotaibi M, Arditi M, Berg AH, et al. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study. BMJ Open. 2021;11:e043584.","journal-title":"BMJ Open"},{"key":"13571_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJMoa2114583","volume":"385","author":"EG Levin","year":"2021","unstructured":"Levin EG, Lustig Y, Cohen C, Fluss R, Indenbaum V, Amit S, et al. Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months. N Engl J Med. 2021;385:1\u201311.","journal-title":"N Engl J Med"},{"key":"13571_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.986085","volume":"13","author":"G Collatuzzo","year":"2022","unstructured":"Collatuzzo G, Visci G, Violante FS, Porru S, Spiteri G, Monaco MGL, et al. Determinants of anti-S immune response at 6 months after COVID-19 vaccination in a multicentric European cohort of healthcare workers \u2013 ORCHESTRA project. Front Immunol. 2022;13:1\u201311.","journal-title":"Front Immunol"},{"key":"13571_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vaccine.2024.126464","volume":"42","author":"A Harrache","year":"2024","unstructured":"Harrache A, Saker K, Mokdad B, Generenaz L, Saade C, Pons S, et al. Anti-RBD IgG dynamics following infection or vaccination. Vaccine. 2024;42:1\u20135.","journal-title":"Vaccine"},{"key":"13571_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jmv.28300","volume":"95","author":"J Reusch","year":"2023","unstructured":"Reusch J, Wagenh\u00e4user I, Gabel A, Eggestein A, H\u00f6hn A, L\u00e2m T, et al. Influencing factors of anti-SARS\u2010CoV\u20102\u2010spike\u2010IgG antibody titers in healthcare workers: A cross\u2010section study. J Med Virol. 2023;95:1\u20139.","journal-title":"J Med Virol"},{"key":"13571_CR15","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1001\/jama.2021.7489","volume":"325","author":"BJ Boyarsky","year":"2021","unstructured":"Boyarsky BJ, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, et al. Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients. JAMA. 2021;325:2204.","journal-title":"JAMA"},{"key":"13571_CR16","unstructured":"Dire\u00e7\u00e3o-Geral da Sa\u00fade. Campanha de Vacina\u00e7\u00e3o Sazonal contra a COVID-19: Outono-Inverno 2023\u20132024. Lisboa; 2023."},{"key":"13571_CR17","unstructured":"Dire\u00e7\u00e3o-Geral da Sa\u00fade. Relat\u00f3rio de vacina\u00e7\u00e3o contra a Gripe e a COVID-19 - \u00c9poca 2023\u20132024. Lisboa; 2024."},{"key":"13571_CR18","doi-asserted-by":"publisher","first-page":"e068996","DOI":"10.1136\/bmjopen-2022-068996","volume":"13","author":"V Gaio","year":"2023","unstructured":"Gaio V, Santos AJ, Amaral P, Faro Viana J, Antunes I, Pacheco V, et al. COVID-19 vaccine effectiveness among healthcare workers: a hospital-based cohort study. BMJ Open. 2023;13:e068996.","journal-title":"BMJ Open"},{"key":"13571_CR19","unstructured":"European Centre for Disease Prevention and Control. Vaccine Effectiveness, Burden and Impact Studies (VEBIS). 2025. https:\/\/www.ecdc.europa.eu\/en\/infectious-disease-topics\/related-public-health-topics\/immunisation-and-vaccines\/vaccine-0. Accessed 24 Jun 2025."},{"key":"13571_CR20","unstructured":"European Centre for Disease Prevention and Control. Generic protocol for ECDC studies of COVID-19 vaccine effectiveness against confirmed SARS-CoV-2 infection using Healthcare Worker Cohorts. Stockholm; 2022."},{"key":"13571_CR21","unstructured":"World Health Organization. Cohort study to measure COVID-19 vaccine effectiveness among health workers in the WHO European Region. Copenhagen; 2021."},{"key":"13571_CR22","unstructured":"Dire\u00e7\u00e3o-Geral da Sa\u00fade. N\u00famero de novos casos e \u00f3bitos por dia. Dire\u00e7\u00e3o-Geral da Sa\u00fade. 2025. https:\/\/covid19.min-saude.pt\/numero-de-novos-casos-e-obitos-por-dia\/. Accessed 4 Jun 2025."},{"key":"13571_CR23","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3390\/microbiolres14020057","volume":"14","author":"P Suwanwattana","year":"2023","unstructured":"Suwanwattana P, Han M, Nopsopon T, Phutrakool P, Samuthpongtorn C, Pongpirul W, et al. Comparison of Antibody Persistence up to 6 Months after Additional Booster Vaccination with ChAdOx1 nCoV-19 Vaccine. Microbiol Res (Pavia). 2023;14:810\u20138.","journal-title":"Microbiol Res (Pavia)"},{"key":"13571_CR24","doi-asserted-by":"publisher","first-page":"m3582","DOI":"10.1136\/bmj.m3582","volume":"371","author":"ASV Shah","year":"2020","unstructured":"Shah ASV, Wood R, Gribben C, Caldwell D, Bishop J, Weir A, et al. Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study. BMJ. 2020;371:m3582.","journal-title":"BMJ"},{"key":"13571_CR25","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","volume":"399","author":"DR Feikin","year":"2022","unstructured":"Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet. 2022;399:924\u201344.","journal-title":"Lancet"},{"key":"13571_CR26","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.cmi.2021.09.005","volume":"28","author":"K Iversen","year":"2022","unstructured":"Iversen K, Kristensen JH, Hasselbalch RB, Pries-Heje M, Nielsen PB, Knudsen AD, et al. Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers. Clin Microbiol Infect. 2022;28:710\u20137.","journal-title":"Clin Microbiol Infect"},{"key":"13571_CR27","doi-asserted-by":"crossref","unstructured":"Goel RR, Painter MM, Apostolidis SA, Mathew D, Meng W, Rosenfeld AM, et al. mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. Science (80-). 2021;374.","DOI":"10.1126\/science.abm0829"},{"key":"13571_CR28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41591-022-01715-4","volume":"28","author":"PR Wratil","year":"2022","unstructured":"Wratil PR, Stern M, Priller A, Willmann A, Almanzar G, Vogel E, et al. Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern. Nat Med. 2022;28:496\u2013503.","journal-title":"Nat Med"},{"key":"13571_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciimmunol.abi6950","volume":"6","author":"RR Goel","year":"2021","unstructured":"Goel RR, Apostolidis SA, Painter MM, Mathew D, Pattekar A, Kuthuru O, et al. Distinct antibody and memory B cell responses in SARSCoV-2 na\u00efve and recovered individuals following mRNA vaccination. Sci Immunol. 2021;6:1\u201319.","journal-title":"Sci Immunol"},{"key":"13571_CR30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.medj.2023.02.004","volume":"4","author":"SC Moore","year":"2023","unstructured":"Moore SC, Kronsteiner B, Longet S, Adele S, Deeks AS, Liu C, et al. Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens. Med. 2023;4:191\u2013e2159.","journal-title":"Med"},{"key":"13571_CR31","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1056\/NEJMoa2118946","volume":"386","author":"Y Goldberg","year":"2022","unstructured":"Goldberg Y, Mandel M, Bar-On YM, Bodenheimer O, Freedman LS, Ash N, et al. Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2. N Engl J Med. 2022;386:2201\u201312.","journal-title":"N Engl J Med"},{"key":"13571_CR32","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S1473-3099(22)00801-5","volume":"23","author":"N Bobrovitz","year":"2023","unstructured":"Bobrovitz N, Ware H, Ma X, Li Z, Hosseini R, Cao C, et al. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression. Lancet Infect Dis. 2023;23:556\u201367.","journal-title":"Lancet Infect Dis"},{"key":"13571_CR33","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.immuni.2024.01.017","volume":"57","author":"K Srivastava","year":"2024","unstructured":"Srivastava K, Carre\u00f1o JM, Gleason C, Monahan B, Singh G, Abbad A, et al. SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase. Immunity. 2024;57:587\u2013e5994.","journal-title":"Immunity"},{"key":"13571_CR34","doi-asserted-by":"crossref","unstructured":"Nouanesengsy A, Semesi A, Quach K, Ivanochko D, Byrne W, Hwang M, et al. Persistence and decay of neutralizing antibody responses elicited by SARS-CoV-2 infection and hybrid immunity in a Canadian cohort. Microbiol Spectr. 2025;13.","DOI":"10.1128\/spectrum.01333-24"},{"key":"13571_CR35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/vaccines10020303","volume":"10","author":"P Ferrara","year":"2022","unstructured":"Ferrara P, Gianfredi V, Tomaselli V, Polosa R. The Effect of Smoking on Humoral Response to COVID-19 Vaccines: A Systematic Review of Epidemiological Studies. Vaccines. 2022;10:303.","journal-title":"Vaccines"},{"key":"13571_CR36","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.vaccine.2021.11.081","volume":"40","author":"J Herzberg","year":"2022","unstructured":"Herzberg J, Vollmer T, Fischer B, Becher H, Becker A, Honarpisheh H, et al. SARS-CoV-2-antibody response in health care workers after vaccination or natural infection in a longitudinal observational study. Vaccine. 2022;40:206\u201312.","journal-title":"Vaccine"},{"key":"13571_CR37","doi-asserted-by":"publisher","first-page":"103805","DOI":"10.1016\/j.ebiom.2021.103805","volume":"75","author":"G Moncunill","year":"2022","unstructured":"Moncunill G, Aguilar R, Ribes M, Ortega N, Rubio R, Salmer\u00f3n G, et al. Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and na\u00efve healthcare workers. eBioMedicine. 2022;75:103805.","journal-title":"eBioMedicine"},{"key":"13571_CR38","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.3390\/v15071574","volume":"15","author":"C Reinkemeyer","year":"2023","unstructured":"Reinkemeyer C, Khazaei Y, Weigert M, Hannes M, Le Gleut R, Plank M, et al. The Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf): Risk Factors and Determinants of Immune Response in Healthcare Workers. Viruses. 2023;15:1574.","journal-title":"Viruses"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13571-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13571-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13571-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:02:47Z","timestamp":1784041367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13571-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13571"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13571-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and its later amendments or comparable ethical standards, as well as the relevant legal and ethical requirements of the institutional research committee. Ethical approval was obtained on September 28, 2023, by the Ethics Committees of the National Institute of Health Doctor Ricardo Jorge and Centro Hospitalar Tondela-Viseu (CHTV). Written informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1327"}}